from The Real Deal Los Angeles2 years agoA joint venture between Tishman Speyer and Los Angeles-based biopharmaceutical investment firm Bellco Capital has raised $3 billion to develop and buy life science properties across the U.S. and Europe. Read at The Real Deal Los Angeles[add][|| ... ]